← Insider buys

E Thomas Corcoran has bought PAHC on 5 days since Aug 2019

Director at Phibro Animal Health Corporation

SEC CIK 0001191763 · Filings on SEC.gov ↗

$753KBought
$0Sold
Jun 2Last buy

E Thomas Corcoran's record

3 months after each buy, from the first price a copier could get.

+17.2%Average
+12.8 ptsVs S&P 500
3 of 3Higher

3 buys since 2019 with 3 months of prices.

Every filing

5 filings since Sep 2019, newest first

About E Thomas Corcoran

E. Thomas Corcoran is a person and serves as an independent director of Phibro Animal Health Corporation (NASDAQ: PAHC), where he has been a member of the board since May 2008 and currently chairs the Audit Committee.( He is an active corporate insider in PAHC stock, with multiple open‑market purchases disclosed on Form 4, including recent acquisitions that increased his direct holdings in the company.( Corcoran also serves on the Board of Trustees of the University of South Alabama, reflecting an ongoing governance role in both corporate and academic settings.(

Corcoran’s career has been centered on the animal health industry, highlighted by his long tenure as President of Fort Dodge Animal Health, a division of Wyeth, Inc., from 1985 until his retirement in 2008, during which he also served on Wyeth’s Management, Operations, Legal, and Human Resources and Benefits committees.( He has held board roles at Putney, Inc. (2010–2016) and Animal Health International, and previously chaired the Animal Health Institute, an industry organization focused on regulatory and policy issues affecting animal health.( He is a recipient of multiple industry honors, including the Animal Pharm Lifetime Achievement Award, the Banfield Industry Leadership Award, the Lifetime Achievement Award from the American Veterinary Distributors Association, and the Industry Leadership Award from the Kansas City Animal Health Corridor, as well as a Distinguished Alumni Award from the University of South Alabama, where he completed his undergraduate degree.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.